The FDA has approved the world’s first pneumococcal disease vaccine designed for adults, signing off on Merck’s Capvaxive (formerly V116) and positioning it to become the primary shot used by seniors ...

On Monday, Marinus revealed that the phase 3 RAISE trial testing ganaxolone, which is an intravenous (IV) formulation of its ...

Two back-to-back pivotal trial wins have rekindled hopes at GSK that once-failed multiple myeloma drug Blenrep could reach more than 3 billion pounds sterling in peak sales after all. | Two ...

From vitamin maker to pharmaceutical specialist and now, contract manufacturer, India’s Lupin is embarking on a new phase of its corporate journey. | From vitamin maker to pharmaceutical specialist ...

Six weeks after revealing that an interim analysis of a phase 3 trial showed that AstraZeneca’s blood cancer drug Calquence ...

AstraZeneca’s Imfinzi has followed GSK’s Jemperli into endometrial cancer. And like its compatriot competitor, the FDA ...

Novo Nordisk CEO Lars Fruergaard Jorgensen has agreed to face questions at a Senate hearing in September after Sen. | Novo ...

LFB Biomanufacturing broke ground on a 20 million euro ($21.4 million) expansion of its manufacturing facility in Alès, ...

The effectiveness of GLP-1 weight-loss drugs sent shockwaves through multiple industries as companies considered a world with ...

A whistleblower case dating back to 2012 culminated in a $150 million guilty verdict for Johnson & Johnson after a New Jersey ...

As argenx homes in on the next indication for its pipeline-in-a-product Vyvgart (efgartigimod), the company is preparing for ...

In the shift toward value-based care, more payers are outsourcing the management of specific therapeutic areas to third-party ...